180 related articles for article (PubMed ID: 21903580)
1. 5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of transferrin receptor 1 (TfR1) and ferrochelatase (Fech) genes.
Ning B; Liu G; Liu Y; Su X; Anderson GJ; Zheng X; Chang Y; Guo M; Liu Y; Zhao Y; Nie G
J Biol Chem; 2011 Oct; 286(43):37196-206. PubMed ID: 21903580
[TBL] [Abstract][Full Text] [Related]
2. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
Schmelz K; Wagner M; Dörken B; Tamm I
Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
[TBL] [Abstract][Full Text] [Related]
3. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis.
Chen W; Dailey HA; Paw BH
Blood; 2010 Jul; 116(4):628-30. PubMed ID: 20427704
[TBL] [Abstract][Full Text] [Related]
4. Regulation of heme biosynthesis: distinct regulatory features in erythroid cells.
Ponka P; Schulman HM
Stem Cells; 1993 May; 11 Suppl 1():24-35. PubMed ID: 8318916
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
Momparler RL; Doré BT; Momparler LF
Cancer Lett; 1990 Oct; 54(1-2):21-8. PubMed ID: 1698532
[TBL] [Abstract][Full Text] [Related]
7. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
[TBL] [Abstract][Full Text] [Related]
8. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.
Zhu WG; Hileman T; Ke Y; Wang P; Lu S; Duan W; Dai Z; Tong T; Villalona-Calero MA; Plass C; Otterson GA
J Biol Chem; 2004 Apr; 279(15):15161-6. PubMed ID: 14722112
[TBL] [Abstract][Full Text] [Related]
9. Erythroid 5-aminolevulinate synthase, ferrochelatase and DMT1 expression in erythroid progenitors: differential pathways for erythropoietin and iron-dependent regulation.
Zoller H; Decristoforo C; Weiss G
Br J Haematol; 2002 Aug; 118(2):619-26. PubMed ID: 12139757
[TBL] [Abstract][Full Text] [Related]
10. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
11. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
12. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma.
Natsume A; Wakabayashi T; Tsujimura K; Shimato S; Ito M; Kuzushima K; Kondo Y; Sekido Y; Kawatsura H; Narita Y; Yoshida J
Int J Cancer; 2008 Jun; 122(11):2542-53. PubMed ID: 18240144
[TBL] [Abstract][Full Text] [Related]
13. FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity.
Yien YY; Shi J; Chen C; Cheung JTM; Grillo AS; Shrestha R; Li L; Zhang X; Kafina MD; Kingsley PD; King MJ; Ablain J; Li H; Zon LI; Palis J; Burke MD; Bauer DE; Orkin SH; Koehler CM; Phillips JD; Kaplan J; Ward DM; Lodish HF; Paw BH
J Biol Chem; 2018 Dec; 293(51):19797-19811. PubMed ID: 30366982
[TBL] [Abstract][Full Text] [Related]
14. Ferrochelatase, glutathione peroxidase and transferrin receptor mRNA synthesis and levels in mouse erythroleukemia cells.
Fuchs O
Stem Cells; 1993 May; 11 Suppl 1():13-23. PubMed ID: 8318915
[TBL] [Abstract][Full Text] [Related]
15. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.
Michalowsky LA; Jones PA
Mol Cell Biol; 1987 Sep; 7(9):3076-83. PubMed ID: 2444874
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis and transferrin receptors.
Moura IC; Hermine O; Lacombe C; Mayeux P
Curr Opin Hematol; 2015 May; 22(3):193-8. PubMed ID: 25767952
[TBL] [Abstract][Full Text] [Related]
17. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 depletion of cartilage oligomeric matrix protein modulates pulmonary artery superoxide and iron metabolism-associated mitochondrial heme biosynthesis.
Yu H; Alruwaili N; Kelly MR; Zhang B; Liu A; Wang Y; Sun D; Wolin MS
Am J Physiol Lung Cell Mol Physiol; 2022 Oct; 323(4):L400-L409. PubMed ID: 35943724
[TBL] [Abstract][Full Text] [Related]
19. Roles of cell division and gene transcription in the methylation of CpG islands.
Bender CM; Gonzalgo ML; Gonzales FA; Nguyen CT; Robertson KD; Jones PA
Mol Cell Biol; 1999 Oct; 19(10):6690-8. PubMed ID: 10490608
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
